Back to funds
View filing
Catalio Capital Management, LP
hedge fundUpdated 8 days agoManaged by Catalio Capital Management, Lp • Latest filing Q2 2026
Portfolio value
$532.1M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
23.8%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $457.1M |
| Q1 2025 | $411.1M |
| Q2 2025 | $476.9M |
| Q3 2025 | $540.9M |
| Q4 2025 | $565.8M |
| Q1 2026 | $478.7M |
| Q2 2026 | $532.1M |
Top holdings
45 positions as of Q4 2025
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GILD GILEAD SCIENCES INC | $35.5M | 289.3K | 6.28% | — |
| 2 | C CELG-RI BRISTOL-MYERS SQUIBB CO | $34.9M | 647.9K | 6.18% | — |
| 3 | B BSX BOSTON SCIENTIFIC CORP | $34.4M | 360.4K | 6.07% | — |
| 4 | B BBIO BRIDGEBIO PHARMA INC | $31.4M | 410.7K | 5.55% | — |
| 5 | L LLY ELI LILLY & CO | $27.9M | 25.9K | 4.92% | — |
| 6 | D DNTH DIANTHUS THERAPEUTICS INC | $26.9M | 653.6K | 4.76% | — |
| 7 | A ASND ASCENDIS PHARMA A/S | $25.4M | 119.3K | 4.50% | — |
| 8 | S SNDX SYNDAX PHARMACEUTICALS INC | $25.1M | 1.20M | 4.44% | — |
| 9 | J JNJ JOHNSON & JOHNSON | $25M | 120.8K | 4.42% | — |
| 10 | R REGN REGENERON PHARMACEUTICALS | $23M | 29.8K | 4.07% | — |
| 11 | G GPCR STRUCTURE THERAPEUTICS INC | $17.6M | 252.9K | 3.11% | — |
| 12 | ? N/A SOLENO THERAPEUTICS INC | $16.7M | 360.3K | 2.95% | — |
| 13 | C CYTK CYTOKINETICS INC | $16.4M | 258.4K | 2.90% | — |
| 14 | E EW EDWARDS LIFESCIENCES CORP | $15.9M | 187.0K | 2.82% | — |
| 15 | I ISRG INTUITIVE SURGICAL INC | $15.4M | 27.2K | 2.72% | — |
| 16 | N NTRA NATERA INC | $14.3M | 62.3K | 2.52% | — |
| 17 | A ADPT ADAPTIVE BIOTECHNOLOGIES COR | $13.3M | 821.2K | 2.36% | — |
| 18 | A AAVXF ABIVAX SA | $13.3M | 98.5K | 2.35% | — |
| 19 | S SUPN SUPERNUS PHARMACEUTICALS INC | $12.8M | 257.5K | 2.26% | — |
| 20 | G GUTS FRACTYL HEALTH INC | $12.1M | 5.49M | 2.14% | — |